Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-02-27
2009-10-20
Kosar, Andrew D. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C424S001690
Reexamination Certificate
active
07605125
ABSTRACT:
A conjugate of formula: V—(Y)a—Z-T: (I), T-X—B—(Y)a—Z-T′: (II), V—(Y)aZ—(Y′)aV′: (III), T-X—B—(Y)a—Z—(Y′)a—X′—B′-T′: (IV), V—(Y)a—Z—(Y′)a—X—B-T: (V), V—(Y)a—Z—X—B—Z′—(Y′)a—(V′)b: (VI), or (W)a—(Y)b—[(Z)c—(Y′)d—(X—B)e—(Y″)f—(Z′)g]h—(Y . . . )i—(W′)j: (VII), in which W and W′ are independently a DNA intercalator or terminal subunit, V and V′ are independently a DNA intercalator, X and X′ are independently a DNA alkylator, B and B′ are the same or different and each is a heteoaromatic residue that is attached to the Nterminus of an alkylator subunit (X or X′), Y, Y′, Y″ and Y′″ are independently a linker, T and T′ are independently terminal subunits, Z and Z′ are independently a polyamide group that binds to the minor groove of DNA, a, b, c, d, f, g, i, and j are independently 0 to 5, and e and h are independently 1 to 5, a composition comprising a conjugate of any of formulae (I)-(VII) and a carrier, and a method for treating cancer in a mammal comprising administering an effective amount of a conjugate of any of formulae (I)-(VII) or a composition comprising same.
REFERENCES:
patent: 4874863 (1989-10-01), Brana et al.
patent: 6060608 (2000-05-01), Boger
Boger et al.,J. Org. Chem., 61, 4894-4912 (1996).
Chang et al.,J. Am. Chem. Soc., 122, 4856-4864 (2000).
Dervan,Bioorganic and Medicinal Chemistry, 9, 2215-2235 (2001).
Dickinson et al.,Proc. Natl. Acad. Sci. U.S.A., 95, 12890-12895 (1998).
Gottesfeld et al.,Nature, 387, 202-205 (1997).
Gupta et al.,Anti-Cancer Drug Design, 11, 581-596 (1996).
Jia et al.,Chem. Commun., 119-120 (1999).
Jia et al.,Heterocyclic Communications,4(6), 557-560 (1998).
Jia et al.,Synlett, 5, 603-606 (2000).
Maeshima et al.,Embo Journal, 20(12), 3218-3228 (2001).
Reddy et al.,Current Medicinal Chemistry, 8, 475-508 (2001).
Soto et al.,Nucleic Acids Research, 29(17), 3638-3645 (2001).
Wang et al.,Gene, 149, 63-67 (1994).
Wurtz et al.,Org. Lett., 3(8), 1201-1203 (2001).
Cholody Marek W.
Hariprakasha Humcha Krishnamurthy
Michejda Christopher
Szekely Zoltan
Audet Maury
Kosar Andrew D.
Leydig , Voit & Mayer, Ltd.
The United States of America as represented by the Department of
LandOfFree
DNA-binding polyamide drug conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA-binding polyamide drug conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA-binding polyamide drug conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4123263